Versican in inflammation and tissue remodeling: The impact on lung disorders
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Versican is a proteoglycan that has many different roles in tissue homeostasis and inflammation. The biochemical structure comprises four different types of the core protein with attached glycosaminoglycans (GAGs) that can be sulfated to various extents and has the capacity to regulate differentiation of different cell types, migration, cell adhesion, proliferation, tissue stabilization and inflammation. Versican's regulatory properties are of importance during both homeostasis and changes that lead to disease progression. The GAGs that are attached to the core protein are of the chondroitin sulfate/dermatan sulfate type and are known to be important in inflammation through interactions with cytokines and growth factors. For a more complex understanding of versican, it is of importance to study the tissue niche, where the wound healing process in both healthy and diseased conditions take place. In previous studies, our group has identified changes in the amount of the multifaceted versican in chronic lung disorders such as asthma, chronic obstructive pulmonary disease, and bronchiolitis obliterans syndrome, which could be a result of pathologic, transforming growth factor β driven, on-going remodeling processes. Reversely, the context of versican in its niche is of great importance since versican has been reported to have a beneficial role in other contexts, e.g. emphysema. Here we explore the vast mechanisms of versican in healthy lung and in lung disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beyond retaining water and cations (for unknown reasons, positively charged glycans are uncommon in nature), extracellular matrix glycosaminoglycans and polysialic acid can act as depots for growth factors and other bioactive molecules, which can be stored locally and released when needed, e.g., during injury and wound healing (86, 556 -561).”
From Biological roles of glycans (2017) · cites this paper as [561]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
The American Journal of Respiratory and Critical Care Medicine
Klocke, R. A., & Sylvester, J. T. (1994) · American Journal of Respiratory and Critical Care Medicine · Cited by 1,710
Towards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,175
DAOUD, G. (1965) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1965.02090030355030 · Cited by 1,171
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100
DAMPening Inflammation by Modulating TLR Signalling
Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 973
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann, D. R., & Ruoslahti, E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08447.x · Cited by 652
Research works printed but not linked: 22
- 2012, European Respiratory Journal, 40, 1362, 10.1183/09031936.00192611 · DOI · Paper page
- 2008, European Respiratory Journal, 32, 61, 10.1183/09031936.00147807 · DOI · Paper page
- 2012, Annals of the Rheumatic Diseases, 71, 761, 10.1136/annrheumdis-2011-200568 · DOI · Paper page
- 2008, European Respiratory Journal, 31, 998, 10.1183/09031936.00017207 · DOI · Paper page
- 2012, Journal of Biological Chemistry, 287, 14122, 10.1074/jbc.m111.324988 · DOI · Paper page
- 2012, Annals of the Rheumatic Diseases, 72, 1575
- 2013, Histology and histopathology, 28, 701
- 2001, Journal of Biological Chemistry, 276, 5228, 10.1074/jbc.m007542200 · DOI · Paper page
- 2006, Circulation Research, 98, 370, 10.1161/01.res.0000202051.28319.c8 · DOI
- 2008, American Journal Of Pathology, 173, 1919, 10.2353/ajpath.2008.070875 · DOI
- 2011, American Journal of Respiratory Cell and Molecular Biology, 45, 915, 10.1165/rcmb.2010-0113oc · DOI · Paper page
- 2012, Journal of Histochemistry & Cytochemistry, 60, 916, 10.1369/0022155412459857 · DOI · Paper page
- 2002, Circulation Research, 90, 481, 10.1161/hh0402.105791 · DOI · Paper page
- 2009, Reproductive Sciences, 16, 1153, 10.1177/1933719109343310 · DOI
- 2007, European Respiratory Journal, 29, 71, 10.1183/09031936.00047905 · DOI
- 2013, Current opinion in cell biology, 25, 619, 10.1016/j.ceb.2013.06.003 · DOI · Paper page
- 2010, American Journal of Respiratory Cell and Molecular Biology, 43, 109, 10.1165/rcmb.2009-0081oc · DOI
- 2005, Journal of Biological Chemistry, 280, 13019, 10.1074/jbc.m411766200 · DOI · Paper page
- 2005, Journal of Clinical Investigation, 115, 2223, 10.1172/jci23755 · DOI · Paper page
- Sch nherr, 1997, Archives of Biochemistry and Biophysics, 339, 353, 10.1006/abbi.1996.9854 · DOI
- 2014, American Journal of Respiratory Cell and Molecular Biology, 51, 26, 10.1165/rcmb.2013-0179oc · DOI
- 2010, Journal of Biological Chemistry, 285, 23241, 10.1074/jbc.m109.084673 · DOI · Paper page
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M., & Ciarmela, P. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx032 · Cited by 321
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
Wight, T. N., Kang, I., Evanko, S. P., Harten, I. A., Chang, M. Y., Pearce, O. M. T., Allen, C. E., & Frevert, C. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00512 · Cited by 268
Therapeutic targets in lung tissue remodelling and fibrosis
Liu, G., Philp, A. M., Corte, T., Travis, M. A., Schilter, H., Hansbro, N. G., Burns, C. J., Eapen, M. S., Sohal, S. S., Burgess, J. K., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107839 · Cited by 249
Provisional matrix: A role for versican and hyaluronan
Wight, T. N. (2017) · Matrix Biology · doi:10.1016/j.matbio.2016.12.001 · Cited by 222
Metadata
- Authors
- Andersson-Sjoland, A., Hallgren, O., Rolandsson, S., Weitoft, M., Tykesson, E., Larsson-Callerfelt, A.-K., Rydell-Tormanen, K., Bjermer, L., Malmstrom, A., Karlsson, J. C., & Westergren-Thorsson, G.
- Affiliations
- Lund University (SE)
- Corresponding author
- Karlsson, J. C.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-03
- Volume
- 25
- Issue
- 3
- Pages
- 243-251
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- PMC
- PMC4310351
- OpenAlex
- W2155048725
- Cited by
- 98
- References
- 100
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 7 · 2020: 12 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 8 · 2015: 4
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Glycobiology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Lunds Universitet
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- versican, proteoglycans, lung inflammation, tissue remodeling, chronic lung disease, asthma, chronic obstructive pulmonary disease, bronchiolitis obliterans syndrome, emphysema, chondroitin sulfate, dermatan sulfate, glycosaminoglycans, TGF-beta, wound healing, cytokine interactions, growth factor interactions
- MeSH terms
- Animals, Extracellular Matrix, Humans, Lung Diseases, Versicans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Versican in inflammation and tissue remodeling: The impact on lung disorders. https://app.cochat.ai/papers/10.1093/glycob/cwu120
- The paper
- Andersson-Sjoland, A., Hallgren, O., Rolandsson, S., Weitoft, M., Tykesson, E., Larsson-Callerfelt, A.-K., Rydell-Tormanen, K., Bjermer, L., Malmstrom, A., Karlsson, J. C., & Westergren-Thorsson, G. (2015). Versican in inflammation and tissue remodeling: The impact on lung disorders. Glycobiology. https://doi.org/10.1093/glycob/cwu120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.